Group One Trading, L.P. Prothena Corp Public LTD CO Transaction History

Group One Trading, L.P.

$2.54 Billion
Q4 2024

A detailed history of Group One Trading, L.P. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Group One Trading, L.P. holds 4,824 shares of PRTA stock, worth $59,721. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,824

Previous 7,434 35.11%

Holding current value

$59,721

Previous $124,000 46.77%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$11.95 - $18.35 $31,189 - $47,893	-2,610 Reduced 35.11%	4,824 $66,000
Q3 2024 Nov 14, 2024	BUY	$16.73 - $24.79 $20,092 - $29,772	1,201 Added 19.27%	7,434 $124,000
Q2 2024 Aug 14, 2024	BUY	$19.54 - $26.15 $76,928 - $102,952	3,937 Added 171.47%	6,233 $128,000
Q1 2024 May 10, 2024	SELL	$24.75 - $40.66 $622,710 - $1.02 Million	-25,160 Reduced 91.64%	2,296 $56,000
Q4 2023 Feb 14, 2024	BUY	$32.31 - $52.32 $887,103 - $1.44 Million	27,456 New	27,456 $997,000
Q3 2022 Nov 09, 2022	BUY	$25.16 - $60.63 $95,935 - $231,182	3,813 New	3,813 $231,000
Q2 2022 Aug 11, 2022	SELL	$22.73 - $39.98 $23,389 - $41,139	-1,029 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$30.27 - $49.22 $95,622 - $155,485	-3,159 Reduced 75.43%	1,029 $38,000
Q4 2021 Feb 11, 2022	BUY	$42.11 - $73.26 $94,789 - $164,908	2,251 Added 116.21%	4,188 $207,000
Q3 2021 Nov 12, 2021	BUY	$48.2 - $78.89 $93,363 - $152,809	1,937 New	1,937 $138,000
Q2 2021 Aug 10, 2021	SELL	$21.63 - $57.65 $163,306 - $435,257	-7,550 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$11.0 - $28.24 $53,856 - $138,263	-4,896 Reduced 39.34%	7,550 $190,000
Q4 2020 Feb 10, 2021	BUY	$10.12 - $13.94 $22,375 - $30,821	2,211 Added 21.6%	12,446 $149,000
Q3 2020 Nov 12, 2020	BUY	$9.93 - $13.47 $16,781 - $22,764	1,690 Added 19.78%	10,235 $102,000
Q2 2020 Aug 13, 2020	SELL	$9.56 - $12.51 $98,630 - $129,065	-10,317 Reduced 54.7%	8,545 $89,000
Q1 2020 May 13, 2020	SELL	$7.54 - $15.77 $65,567 - $137,135	-8,696 Reduced 31.56%	18,862 $202,000
Q4 2019 Feb 10, 2020	BUY	$7.48 - $17.01 $159,877 - $363,571	21,374 Added 345.63%	27,558 $436,000
Q3 2019 Nov 12, 2019	SELL	$6.89 - $10.45 $48,939 - $74,226	-7,103 Reduced 53.46%	6,184 $48,000
Q2 2019 Aug 09, 2019	BUY	$8.85 - $12.49 $66,906 - $94,424	7,560 Added 132.01%	13,287 $140,000
Q1 2019 May 13, 2019	SELL	$10.32 - $14.49 $337,020 - $473,199	-32,657 Reduced 85.08%	5,727 $69,000
Q4 2018 Feb 06, 2019	BUY	$8.73 - $13.74 $16,176 - $25,460	1,853 Added 5.07%	38,384 $395,000
Q3 2018 Nov 08, 2018	SELL	$12.7 - $15.79 $148,551 - $184,695	-11,697 Reduced 24.25%	36,531 $478,000
Q2 2018 Aug 14, 2018	BUY	$10.99 - $44.21 $341,448 - $1.37 Million	31,069 Added 181.07%	48,228 $703,000
Q1 2018 May 11, 2018	BUY	$27.95 - $45.04 $387,722 - $624,794	13,872 Added 422.03%	17,159 $630,000
Q4 2017 Feb 09, 2018	BUY	$35.44 - $63.76 $116,491 - $209,579	3,287	3,287 $123,000

Others Institutions Holding PRTA

# of Institutions

197

Shares Held

39.4M

Call Options Held

601K

Put Options Held

259K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $581M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Prothena Corp Public LTD CO Transaction History